Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Raskova

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Nephrology|January 11, 1991
Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro studyD Donati, D Degiannis, L Homer, et al.
Journal of the American Society of Nephrology : JASN|April 11, 1992
Effects of hemodialysis on activation of lymphocytes: analysis by an in vitro dialysis modelD Donati, D Degiannis, N Combates, et al.
ASAIO Transactions|July 11, 1991
Evidence of mononuclear cell activation by hemodialysisD Donati, D Degiannis, N Combates, et al.
International Journal of Immunopharmacology|October 1, 1993
IL-4 receptor expression by SAC-activated B-lymphocytes: its role in B-cell proliferation and the effect of cyclosporine (CsA), prednisolone and verapamilD Degiannis, N Hornung, D Luke-Gustites, et al.
Transplantation|August 11, 1992
Binding of phycoerythrin-conjugated interleukin-6 to in vitro-activated human peripheral blood mononuclear cells--effect of immunosuppressive agents and of a calcium channel blockerD Degiannis, D Luke-Gustites, N Mikhail, et al.
Clinical Immunology and Immunopathology|August 1, 1990
Soluble and cellular markers of immune activation in patients with systemic sclerosisD Degiannis, J R Seibold, M Czarnecki, et al.
Arthritis and Rheumatism|March 1, 1990
Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlationsD Degiannis, J R Seibold, M Czarnecki, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1989
Independent learning in pathology. Does it work?J Raskova, E G Martin, R L Trelstad, et al.
The Journal of Experimental Medicine|March 1, 1986
Adenovirus tumor-specific transplantation antigen is a function of the E1A early regionY Sawada, D Urbanelli, J Raskova, et al.
Nephron|January 11, 1991
Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and releaseD Donati, D Degiannis, L Homer, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Nephrology|January 11, 1991
Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro studyD Donati, D Degiannis, L Homer, et al.
Journal of the American Society of Nephrology : JASN|April 11, 1992
Effects of hemodialysis on activation of lymphocytes: analysis by an in vitro dialysis modelD Donati, D Degiannis, N Combates, et al.
ASAIO Transactions|July 11, 1991
Evidence of mononuclear cell activation by hemodialysisD Donati, D Degiannis, N Combates, et al.
International Journal of Immunopharmacology|October 1, 1993
IL-4 receptor expression by SAC-activated B-lymphocytes: its role in B-cell proliferation and the effect of cyclosporine (CsA), prednisolone and verapamilD Degiannis, N Hornung, D Luke-Gustites, et al.
Transplantation|August 11, 1992
Binding of phycoerythrin-conjugated interleukin-6 to in vitro-activated human peripheral blood mononuclear cells--effect of immunosuppressive agents and of a calcium channel blockerD Degiannis, D Luke-Gustites, N Mikhail, et al.
Clinical Immunology and Immunopathology|August 1, 1990
Soluble and cellular markers of immune activation in patients with systemic sclerosisD Degiannis, J R Seibold, M Czarnecki, et al.
Arthritis and Rheumatism|March 1, 1990
Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlationsD Degiannis, J R Seibold, M Czarnecki, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1989
Independent learning in pathology. Does it work?J Raskova, E G Martin, R L Trelstad, et al.
The Journal of Experimental Medicine|March 1, 1986
Adenovirus tumor-specific transplantation antigen is a function of the E1A early regionY Sawada, D Urbanelli, J Raskova, et al.
Nephron|January 11, 1991
Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and releaseD Donati, D Degiannis, L Homer, et al.
Pageof 6